Cheng20 tested the feasibility of epidermal growth factor receptor (EGFR) gene‐targeted chimeric antigen receptor T‐cell immunotherapy (CAR‐T) cells for the treatment of ESCC in a large Chinese sample by whole genome sequencing (WGS) and RNA‐seq analysis. The gene discussed is EGFR; the disease is esophageal squamous cell carcinoma.